Sylvia Lee

1.7k total citations · 1 hit paper
44 papers, 1.3k citations indexed

About

Sylvia Lee is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sylvia Lee has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Sylvia Lee's work include Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (13 papers) and Immunotherapy and Immune Responses (6 papers). Sylvia Lee is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (13 papers) and Immunotherapy and Immune Responses (6 papers). Sylvia Lee collaborates with scholars based in United States, United Kingdom and Spain. Sylvia Lee's co-authors include Kim Margolin, Álvaro Acosta-Serrano, Michael A. J. Ferguson, Laurence Tetley, Michaël Schumacher, Martin E. Feder, Anatoli I. Yashin, Julie Ho, Robertson Mackenzie and Andrzej Bartke and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Cancer.

In The Last Decade

Sylvia Lee

42 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokines in Cancer Immunotherapy

2011 520 citations Sylvia Lee, Kim Margolin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sylvia Lee United States	16	542	453	324	122	114	44	1.3k
Jennifer Ferguson United Kingdom	21	349 0.6×	185 0.4×	565 1.7×	97 0.8×	52 0.5×	37	1.4k
Enrrico Bloise Brazil	27	391 0.7×	329 0.7×	377 1.2×	78 0.6×	50 0.4×	74	2.0k
Xiangyu Chen China	20	121 0.2×	311 0.7×	293 0.9×	88 0.7×	69 0.6×	115	1.2k
Dimitre R. Simeonov United States	15	328 0.6×	384 0.8×	922 2.8×	384 3.1×	77 0.7×	20	1.8k
Riikka Lund Finland	25	266 0.5×	601 1.3×	1.0k 3.1×	180 1.5×	52 0.5×	47	1.8k
Ester Del Duca Italy	28	162 0.3×	532 1.2×	281 0.9×	64 0.5×	48 0.4×	116	2.6k
Noriyuki Kuroda Japan	21	173 0.3×	743 1.6×	304 0.9×	170 1.4×	57 0.5×	59	1.5k
Norbert Wikonkál Hungary	18	258 0.5×	123 0.3×	317 1.0×	95 0.8×	69 0.6×	81	1.3k
David Chao Taiwan	23	601 1.1×	682 1.5×	576 1.8×	98 0.8×	50 0.4×	72	2.2k
John C. Morris United States	23	754 1.4×	498 1.1×	827 2.6×	366 3.0×	91 0.8×	43	2.1k

Countries citing papers authored by Sylvia Lee

Since Specialization

Citations

This map shows the geographic impact of Sylvia Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Lee more than expected).

Fields of papers citing papers by Sylvia Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Lee. The network helps show where Sylvia Lee may publish in the future.

Co-authorship network of co-authors of Sylvia Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Lee. A scholar is included among the top collaborators of Sylvia Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Lee. Sylvia Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Sylvia, Liam Byrne, Yuren Wei, et al.. (2025). Effects of Supplementation with Microalgae Extract from Tetradesmus obliquus Strain Mi175.B1.a on Gastrointestinal Symptoms and Mental Health in Healthy Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Trial. Nutrients. 17(6). 960–960. 2 indexed citations

Safyan, Rachael A., Mary W. Redman, Andrew L. Coveler, et al.. (2025). Phase I study of autologous CD8+ and CD4+ transgenic T cells expressing high-affinity KRAS G12V mutation-specific T cell receptors (FH-A11KRASG12V-TCR) in patients with metastatic pancreatic, colorectal, and non-small cell lung cancers with KRAS G12V mutations.. Journal of Clinical Oncology. 43(4_suppl).

Lee, Sylvia, Michelle Butler, S. Holmes, et al.. (2025). Feasibility and Tolerability of Daily Microgreen Consumption in Healthy Middle-Aged/Older Adults: A Randomized, Open-Label, Controlled Crossover Trial. Nutrients. 17(3). 467–467. 3 indexed citations

Voutsinas, Jenna, Jonathan R. Fromm, Renato Martins, et al.. (2024). Long term outcomes in patients with recurrent/metastatic (R/M) salivary gland cancer (SGC) treated with immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 42(16_suppl). e18063–e18063. 1 indexed citations

Zakharia, Yousef, Sylvia Lee, Robert M. Jotte, et al.. (2024). Phase 2 trial of brentuximab vedotin (BV) with pembrolizumab (pembro) in patients with previously treated metastatic non-small cell lung cancer (NSCLC) or cutaneous melanoma (SGN35-033): Overall survival.. Journal of Clinical Oncology. 42(16_suppl). 2617–2617. 1 indexed citations

Litwin, Nicole S., Sylvia Lee, M. Smith, et al.. (2023). Daily blueberry consumption for 12 weeks improves endothelial function in postmenopausal women with above-normal blood pressure through reductions in oxidative stress: a randomized controlled trial. Food & Function. 14(6). 2621–2641. 25 indexed citations

Lee, Sylvia, et al.. (2023). Protective effects of blueberries on vascular function: A narrative review of preclinical and clinical evidence. Nutrition Research. 120. 20–57. 13 indexed citations

Rodriguez, Cristina P., Vicky Wu, Jenna Voutsinas, et al.. (2023). Dual PD1 and CTLA4 immune checkpoint blockade and hypofractionated radiation in patients with salivary gland cancers.. Journal of Clinical Oncology. 41(16_suppl). 6011–6011. 1 indexed citations

Yan, Wei, Minghui Cao, Xianhui Ruan, et al.. (2022). Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis. Nature Cell Biology. 24(5). 793–804. 56 indexed citations

10.

Bowen, Stephen R., Daniel S. Hippe, Hannah Thomas, et al.. (2021). Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer. Advances in Radiation Oncology. 7(2). 100857–100857. 3 indexed citations

11.

Gettinger, Scott, Harriet M. Kluger, Adam J. Schoenfeld, et al.. (2021). Abstract CT235: A Phase 2, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumors. Cancer Research. 81(13_Supplement). CT235–CT235. 1 indexed citations

12.

Baik, Christina S., Sylvia Lee, Rafael Santana-Dávila, et al.. (2021). A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy. Cancer Treatment and Research Communications. 28. 100416–100416. 1 indexed citations

13.

Yuan, Ziqiang, Asha Adem, George Zhang, et al.. (2018). Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation. Cancer Gene Therapy. 26(3-4). 94–102. 5 indexed citations

14.

Sánchez-Vidaña, Dalinda Isabel, Alan H. L. Chan, Sylvia Lee, et al.. (2016). Repeated treatment with oxytocin promotes hippocampal cell proliferation, dendritic maturation and affects socio-emotional behavior. Neuroscience. 333. 65–77. 54 indexed citations

15.

Kommoss, Stefan, Michael S. Anglesio, Robertson Mackenzie, et al.. (2013). FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Modern Pathology. 26(6). 860–867. 62 indexed citations

16.

Lee, Sylvia & Kim Margolin. (2012). Tumor-Infiltrating Lymphocytes in Melanoma. Current Oncology Reports. 14(5). 468–474. 73 indexed citations

17.

Schneiderman, Jane E., Derek Stephens, Sylvia Lee, et al.. (2011). A cross‐sectional study of overweight in pediatric survivors of acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer. 57(7). 1204–1209. 39 indexed citations

18.

Lee, Sylvia, et al.. (2006). GPI-anchored Proteins and Free GPI Glycolipids of Procyclic FormTrypanosoma bruceiAre Nonessential for Growth, Are Required for Colonization of the Tsetse Fly, and Are Not the Only Components of the Surface Coat. Molecular Biology of the Cell. 17(12). 5265–5274. 56 indexed citations

19.

Leroi, Armand M., Andrzej Bartke, Giovanna De Benedictis, et al.. (2004). What evidence is there for the existence of individual genes with antagonistic pleiotropic effects?. Mechanisms of Ageing and Development. 126(3). 421–429. 95 indexed citations

20.

Pegelow, Charles H., et al.. (1979). Lead screening in sickle cell disease. The Journal of Pediatrics. 95(5). 738–740. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact